Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Shiratori, Y.
Right arrow Articles by Omata, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shiratori, Y.
Right arrow Articles by Omata, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology 30:213-214 (2000)
© 2000 Foundation for Promotion of Cancer Research

Effects of Interferon Therapy on Inhibition of Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis C

Yasushi Shiratori, Haruhiko Yoshida and Masao Omata

Department of Gastroenterology, University of Tokyo, Tokyo, Japan

The natural history of chronic HCV infection suggests that there is a sequential but slow progression from acute HCV infection to chronic infection, leading to cirrhosis and death from either liver failure or hepatocellular carcinoma (HCC) (1–4). Although chronic hepatitis, cirrhosis and HCC are accepted sequelae, the rate of development of decompensation and/or HCC to which they contribute to mortality are not well known. Because prospective studies with long-term observation are rare, only data from selected cases or studies gathered over relatively short-follow up periods have been collected.

After the introduction of interferon (IFN) for chronic hepatitis C . . . [Full Text of this Article]


    REFERENCES
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?